DESCRIPTION
The biotech revolution continues its advance into unchartered territory, delivering new applications and linking areas as diverse as genomics/proteomics, medical diagnostics, medical therapeutics, drug delivery, and agribusiness. Largely due to the Boston area's unparalleled academic infrastructure, the region is home to many of the biotech industry's leaders.
This event will bring together some of those leaders to discuss the industry's relationship to academia and to explore how those links will shape the future emergence of the industry and its effects upon our lives. The audience will be a mix of leading entrepreneurs and established corporations, academic researchers, venture capitalists, and governmental agents.
Keynote:
Robert Coughlin, President of the Massachusetts Biotechnology Council (MBC)
Moderator:
Barry karger, Professor, Northeastern University, James L. Waters Chair in Analytical Chemistry
Panelists:
Steven Tregay, Managing Director, Novartis Option Fund
Jonathan Fleming, Managing General Partner, Oxford Biosciences
Dennis Crowley, Vice President of Corporate Development and Licensing, Covidien
Eric L. Miller, Professor, Department of Electrical and Computer Engineering at Tufts University
For more information about this event, please visit: http://www.entretechforum.org/mm_Oct16_2007.htm